Experimental combo therapy for advanced cancer shows promise but trial ends early

NCT ID NCT05846646

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a new treatment for people with non-small cell lung cancer or kidney cancer that had spread to up to six spots in the body. The treatment combined a special type of radiation therapy (PULSAR) with immunotherapy drugs (pembrolizumab or nivolumab), with or without an experimental drug called IMSA101 that boosts the immune system. The goal was to see if adding IMSA101 made the treatment safer and more effective. The trial was stopped early after enrolling only 6 participants, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor College of Medicine Medical Center

    Houston, Texas, 77030, United States

  • City of Hope Orange County Lennar Foundation Cancer Center

    Irvine, California, 92618, United States

  • Huntsman Cancer Institute, University of Utah

    Salt Lake City, Utah, 84112, United States

  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

    New York, New York, 10016, United States

  • Louis Stokes Cleveland VA Medical Center

    Cleveland, Ohio, 44106, United States

  • MetroHealth Medical Center

    Cleveland, Ohio, 44109, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08903, United States

  • The University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, 53792, United States